NCT00653120

Bioavailability Study of Propranolol Under Fasting Conditions

Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Par Propranolol 160 mg With That of Inderal-LA Propranolol 160 mg in Healthy Subjects Under Fasting Conditions.

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Par Pharmaceutical, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To compare the single-dose bioavailability of Propranolol 160 Mg ER capsules with Inderal-La

Detailed description

To compare the single -dose bioavailability of Par Propranolol 160 Mg ER capsules with Wyeth Pharmaceuticals, Inderal-LA, Propranolol under fasting conditions.

Conditions

• To Determine Bioequivalence Under Fasting Conditions

Interventions

Type	Name	Description
DRUG	Propranolol	ER capsules, 160 mg, single-dose
DRUG	Inderal-LA	ER capsules, 160 mg, single-dose

Timeline

• Start date: 2005-05-01
• Primary completion: 2005-11-01
• Completion: 2005-11-01
• First posted: 2008-04-04
• Last updated: 2008-04-04

Locations

1 site across 1 country: Canada